• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过实施科学将翻译指南转化为实践:脂质学的最新进展。

Translating guidelines into practice via implementation science: an update in lipidology.

机构信息

Genomic Medicine Institute Geisinger, Danville, Pennsylvania, USA.

Heart and Vascular Institute, Geisinger, Danville, Pennsylvania, USA.

出版信息

Curr Opin Lipidol. 2022 Dec 1;33(6):336-341. doi: 10.1097/MOL.0000000000000835. Epub 2022 Jun 27.

DOI:10.1097/MOL.0000000000000835
PMID:35779062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9640274/
Abstract

PURPOSE OF REVIEW

Guidelines provide recommendations for clinicians based on the best available evidence and informed by clinical expertise. These recommendations often fail to be utilized by clinicians hindering the translation of evidence into practice. The purpose of this review is to describe novel ways in which implementation science has been used to improve translation of guidelines into clinical practice in the field of lipidology.

RECENT FINDINGS

We searched PubMed for articles related to guideline implementation in lipidology published in 2021 and 2022. Identified articles were categorized into three domains: first, poor uptake of guideline recommendations in practice; second, implementation science as a solution to improve care; and third, examples of how implementation science can be incorporated into guidelines.

SUMMARY

The field of lipidology has identified that many guideline recommendations fail to be translated into practice and has started to utilize methods from implementation science to assess ways to shrink this gap. Future work should focus on deploying tools from implementation science to address current gaps in guideline development. Such as, developing a systematic approach to restructure guideline recommendations so they are implementable in practice and aid in clinicians' ability to easily translate them into practice.

摘要

目的综述

指南根据现有最佳证据并结合临床专业知识为临床医生提供建议。这些建议往往未能被临床医生所采用,从而阻碍了证据向实践的转化。本综述的目的在于描述实施科学在改善脂质学领域指南向临床实践转化方面的新方法。

最近的发现

我们在 PubMed 上搜索了 2021 年和 2022 年发表的与脂质学指南实施相关的文章。确定的文章分为三个领域:第一,指南建议在实践中采纳率低;第二,实施科学是改善护理的解决方案;第三,实施科学如何融入指南的例子。

总结

脂质学领域已经认识到许多指南建议未能转化为实践,并且已经开始利用实施科学的方法来评估缩小这一差距的方法。未来的工作应侧重于部署实施科学工具来解决指南制定中的当前差距。例如,制定一种系统的方法来重组指南建议,使它们在实践中具有可操作性,并帮助临床医生更容易地将其转化为实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/344d3add32c0/colip-33-336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/d8fc9c20580b/colip-33-336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/9a8d47457775/colip-33-336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/366b18873d01/colip-33-336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/344d3add32c0/colip-33-336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/d8fc9c20580b/colip-33-336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/9a8d47457775/colip-33-336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/366b18873d01/colip-33-336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a4a/9640274/344d3add32c0/colip-33-336-g004.jpg

相似文献

1
Translating guidelines into practice via implementation science: an update in lipidology.通过实施科学将翻译指南转化为实践:脂质学的最新进展。
Curr Opin Lipidol. 2022 Dec 1;33(6):336-341. doi: 10.1097/MOL.0000000000000835. Epub 2022 Jun 27.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Acute post-stroke aphasia management: An implementation science study protocol using a behavioural approach to support practice change.急性脑卒中后失语症管理:使用行为方法支持实践改变的实施科学研究方案。
Int J Lang Commun Disord. 2023 May;58(3):968-976. doi: 10.1111/1460-6984.12816. Epub 2022 Dec 15.
4
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见†。
Hum Reprod. 2023 Sep 5;38(9):1655-1679. doi: 10.1093/humrep/dead156.
5
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463.
6
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见。
Fertil Steril. 2023 Oct;120(4):767-793. doi: 10.1016/j.fertnstert.2023.07.025. Epub 2023 Aug 14.
7
Improving Guideline Adherence in Urology.提高泌尿科指南依从性。
Eur Urol Focus. 2022 Sep;8(5):1545-1552. doi: 10.1016/j.euf.2021.10.007. Epub 2021 Oct 24.
8
Agents of change: establishing quality improvement collaboratives to improve adherence to Australian clinical guidelines for dementia care.变革推动者:建立质量改进合作组织,以提高对澳大利亚痴呆症护理临床指南的依从性。
Implement Sci. 2018 Sep 24;13(1):123. doi: 10.1186/s13012-018-0820-z.
9
Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary.临床实践指南:突发性聋(更新)执行摘要。
Otolaryngol Head Neck Surg. 2019 Aug;161(2):195-210. doi: 10.1177/0194599819859883.
10
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.2023 年多囊卵巢综合征评估和管理国际循证指南推荐意见。
Eur J Endocrinol. 2023 Aug 2;189(2):G43-G64. doi: 10.1093/ejendo/lvad096.

引用本文的文献

1
Evaluating the implementation of adult smoking cessation programs in community settings: a scoping review.评估社区环境中成人戒烟项目的实施情况:一项范围综述
Front Public Health. 2025 Mar 28;12:1495151. doi: 10.3389/fpubh.2024.1495151. eCollection 2024.
2
Learnings from Implementation Strategies to Improve Lipid Management.从改善血脂管理的实施策略中获得的经验教训。
Curr Cardiol Rep. 2025 Jan 8;27(1):9. doi: 10.1007/s11886-024-02174-8.
3
Adequacy of Fatty Acids Consumption Among Individuals in Secondary Cardiovascular Prevention.

本文引用的文献

1
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol.针对家族性高胆固醇血症患者实现全员覆盖的协作方法:CARE-FH方案。
J Pers Med. 2022 Apr 9;12(4):606. doi: 10.3390/jpm12040606.
2
Minimally Disruptive Medicine: Progress 10 Years Later.微创医学:十年后的进展
Mayo Clin Proc. 2022 Feb;97(2):210-220. doi: 10.1016/j.mayocp.2021.09.003.
3
Current practices and challenges in adaptation of clinical guidelines: a qualitative study based on semistructured interviews.现行临床指南适应实践及挑战:基于半结构式访谈的定性研究
在二级心血管预防人群中,脂肪酸的摄入量是否充足。
Arq Bras Cardiol. 2024 Apr 5;121(3):e20230487. doi: 10.36660/abc.20230487. eCollection 2024.
4
Real-world utilization of guideline-directed genetic testing in inherited cardiovascular diseases.遗传性心血管疾病中指南指导下基因检测的真实世界应用情况
Front Cardiovasc Med. 2023 Oct 17;10:1272433. doi: 10.3389/fcvm.2023.1272433. eCollection 2023.
5
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.国际动脉粥样硬化学会家族性高胆固醇血症管理最佳实践实施指南。
Nat Rev Cardiol. 2023 Dec;20(12):845-869. doi: 10.1038/s41569-023-00892-0. Epub 2023 Jun 15.
6
Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.设计改善家族性高胆固醇血症家庭识别、级联检测及管理的实施策略:一种干预映射方法。
Front Health Serv. 2023 Apr 28;3:1104311. doi: 10.3389/frhs.2023.1104311. eCollection 2023.
BMJ Open. 2021 Dec 2;11(12):e053587. doi: 10.1136/bmjopen-2021-053587.
4
Applying implementation science to improve care for familial hypercholesterolemia.应用实施科学改善家族性高胆固醇血症的护理。
Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):141-151. doi: 10.1097/MED.0000000000000692.
5
Improving clinical practice guidelines with implementation science.运用实施科学改进临床实践指南。
Nat Rev Cardiol. 2022 Jan;19(1):3-4. doi: 10.1038/s41569-021-00645-x.
6
Implementing cardiovascular disease preventive care guidelines in general practice: an opportunity missed.在全科医疗中实施心血管疾病预防护理指南:错失的机遇。
Med J Aust. 2021 Aug 16;215(4):189-189.e1. doi: 10.5694/mja2.51190. Epub 2021 Jul 21.
7
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.在美国动脉粥样硬化性心血管疾病患者登记库GOULD中,降脂疗法两年以上的使用情况。
JAMA Cardiol. 2021 Sep 1;6(9):1060-1068. doi: 10.1001/jamacardio.2021.1810.
8
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.在心血管疾病高危人群中,初级预防工作开展得很差:来自欧洲心脏病学会 EURObservational Research Programme EUROASPIRE V 调查的 16 个欧洲国家的报告。
Eur J Prev Cardiol. 2021 May 8;28(4):370-379. doi: 10.1177/2047487320908698. Epub 2020 Mar 20.
9
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.降脂联合治疗高风险和极高风险患者的实用指南:欧洲动脉粥样硬化学会工作组的声明。
Atherosclerosis. 2021 May;325:99-109. doi: 10.1016/j.atherosclerosis.2021.03.039. Epub 2021 Apr 13.
10
Increasing risk-concordant cardiovascular care in diverse health systems: a mixed methods pragmatic stepped wedge cluster randomized implementation trial of shared decision making (SDM4IP).在不同卫生系统中增加风险协调一致的心血管护理:一项关于共同决策的混合方法实用阶梯楔形整群随机实施试验(SDM4IP)
Implement Sci Commun. 2021 Apr 21;2(1):43. doi: 10.1186/s43058-021-00145-6.